Details of the Drug

General Information of Drug (ID: DMYR8AG)

• Drug Name: INB-200

Indication

Disease Entry	ICD 11	Status	REF
Glioblastoma of brain	2A00.00	Phase 1	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: DVZN13

References

• [1] Clinical pipeline report, company report or official report of IN8bio.